Form EFFECT Cyclacel Pharmaceuticals
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 11, 2025 |
| Accession Number: | 0001641172-25-026154 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deep Sea Minerals Clarifies Disclosure at the Request of the BCSC
- In HelloNation, Autism Expert Veronica Glickman of Autism Behavioral and Educational Services, Inc. (ABES, Inc.) Highlights the Benefits of Early Intervention in ABA Therapy
- Bladex announces Net Profit of $66.5 Million for the Second Quarter 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
